Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Ermycin 250 mg film-coated tablets.
Ermycin 500 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Ermycin 250 mg film-coated tablets are pink, round, scored, film-coated tablets with Remedica’s logo on one side. Ermycin 500 mg film-coated tablets are white, modified capsule shaped, scored, film-coated tablets. The tablets can be divided into two equal doses. |
Ermycin 250 mg film-coated tablets: Each tablet contains erythromycin stearate equivalent to 250 mg erythromycin.
Ermycin 500 mg film-coated tablets: Each tablet contains erythromycin stearate equivalent to 500 mg erythromycin.
Excipients with known effect:
Each Ermycin 250 mg film-coated tablet contains 0.36 mg Ponceau 4R E124.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Erythromycin |
Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism. |
| List of Excipients |
|---|
Ermycin 250 mg film-coated tabletsCore: Povidone Coating: Hypromellose Ermycin 500 mg film-coated tabletsCore: Povidone Coating: Hypromellose |
Ermycin 250 mg film-coated tablets:
PVC/Aluminium blisters. Pack sizes of 20, 100 and 1000 film-coated tablets.
PP containers with PE closure. Pack size of 1000 film-coated tablets.
Ermycin 500 mg film-coated tablets:
PVC/Aluminium blisters. Pack sizes of 12, 20, 100 and 1000 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Ermycin 250 mg film-coated tablets: 9340
Ermycin 500 mg film-coated tablets: 16033
Ermycin 250 mg film-coated tablets:
Date of first authorization: 26 May 1984
Date of latest renewal: 22 December 2011
Ermycin 500 mg film-coated tablets:
Date of first authorization: 03 February 1995
Date of latest renewal: 12 July 2012
| Drug | Countries | |
|---|---|---|
| ERMYCIN | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
